Clinical Trials Logo

Clinical Trial Summary

To evaluate the pharmacokinetic characteristics, pharmacodynamic characteristics, safety, tolerability and immunogenicity of SHR-2017 injection in patients with bone metastases, and to evaluate the efficacy of SHR-2017 injection in the treatment of skeletal-related event and cancer pain.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06380881
Study type Interventional
Source Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Contact Qin Liu
Phone +0518-82342973
Email qin.liu@hengrui.com
Status Not yet recruiting
Phase Phase 1
Start date April 2024
Completion date July 2025